Research

New Centres Sought for C.Difficile Study

The RAPID trial is looking to open more recruitment centres. We are examining the effectiveness of Rifaximin in preventing recurrence of C.difficile infection. Professor Robin Spiller is the Chief Investigator of this NIHR portfolio study (UKCRN ID: 12990), being sponsored by the University of Nottingham.

To express interest and receive more information, please contact Nafisa Boota (Trial Manager, Nottingham Clinical Trials Unit). Telephone: +44 (0)115 884 4924. Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it .